Ready Or Not: FDA Accepting Adaptive Trial Applications
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Who will have access to unblinded clinical trial data and what that structure would look like is one of the biggest adaptive trial issues yet to be hammered out between FDA and industry, FDA officials said.